Stockpolly
Search
PAVM · NASDAQ · Medical - Devices

PAVmed (PAVM)

Building digital oncology, esophageal diagnostics, and medical-device platforms through a shared-services model.

$5.28
Pre-market−0.37 (−6.55%)
At close$5.65(+13.23%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue111110000000
Cost of revenue222210000000
Gross profit−1−1−1−100000000
15161313115555787
Research & development342221111212
1112111110454417,15575
Selling & marketing45443000091600
General & administrative77777444416,23865
Other expenses110000000−17,15000
Operating income−16−16−14−14−12−5−5−5−5−7−8−7
−6−1−4−172624−8−1470
Interest income000000000000
Interest expense000000000000
Other non-operating income6141−72−6−2481−4−70
Income before tax−22−17−19−1561119−12−6−3−1−7
Net income from continuing operations−22−17−19−1561119−12−6−3−1−7
Net income−18−14−15−1164119−12−5−10−5
EPS, basic−$71.35−$58.07−$78.62−$35.75$192.84$3.61$38.26−$22.20−$8.70−$2.37−$4.42−$0.87
EPS, diluted−$71.35−$58.07−$78.62−$35.75$43.22$3.61$10.11−$22.20−$8.70−$2.37−$4.42−$0.87
Weighted average shares, basic000000011126
Weighted average shares, diluted000010211126
EBITDA−21−17−18−1561119−12−6−3−1−7
Depreciation & amortization111000000000
EBIT−22−17−18−1561119−12−6−3−1−7